MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
about
MiR-503 Promotes Bone Formation in Distraction Osteogenesis through Suppressing Smurf1 ExpressionMiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptorAn integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells.Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.MicroRNA-503-5p inhibits stretch-induced osteogenic differentiation and bone formation.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker.Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1FARNA: knowledgebase of inferred functions of non-coding RNA transcripts.MicroRNA-503 inhibits the proliferation and invasion of breast cancer cells via targeting insulin-like growth factor 1 receptor.MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
P2860
Q33671952-4BF84D4A-2C98-4EA8-994E-8A01E7426491Q37021246-E5911E14-00CE-4F71-BDDF-9598E369867BQ37268606-3613394F-48CD-4DCB-A39E-91CBC341E50BQ37708863-091E2E96-8F96-4909-BC1D-E7A4FC78D1BAQ38290132-5795FB62-50F6-42FF-8584-795E1A1908FDQ38958559-7BD8E224-99A9-49CB-A1FB-D71683852200Q40570815-1B3867F4-0EC0-498C-B61E-0A3BFA3C566BQ41024213-B86B476D-539E-47CA-B469-9657BB959A5CQ41193504-6B6AE081-9CE3-4FDD-A55E-474CCC87F4F8Q41821320-17E216D3-AD1F-4E25-9AE6-6548D34D8076Q42347150-07C54130-2FD8-434F-8CFB-27280392FA7EQ42678973-37946D63-3DE9-4316-8D45-462134156D94Q46342512-FFDA36EC-E4E8-48C8-9774-EEC71EE3AB50Q47667794-0D852DA0-343E-4B23-B9A9-A39FFD5521BFQ55261613-AEC098A4-A043-44E9-B542-A9B07E7FD55F
P2860
MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@en
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@nl
type
label
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@en
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@nl
prefLabel
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@en
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@nl
P2093
P2860
P1433
P1476
MiR-503 inhibited cell prolife ...... suppressing CCND1 expression.
@en
P2093
Haoming Xia
Jianting Long
P2860
P2888
P304
P356
10.1007/S13277-015-3623-8
P577
2015-06-06T00:00:00Z